Press Releases

 Filter by Provider

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of the next-generation of Lens, its pioneering agentic AI platform designed to accelerate drug development and research. This evolution seamlessly connects Tempus’ multimodal data, AI tooling and computational infrastructure to deliver actionable insights at the pace required for drug development.

Moein Surgical Arts is highlighting alloClae, a modern non-surgical body contouring option for select patients seeking refined volume enhancement, smoother body contours, and improved aesthetic balance without traditional fat-harvesting surgery.

WASHINGTON, D.C. / ACCESS Newswire / May 31, 2026 / Following President Donald Trump's Truth Social post declaring "TIME TO AUDIT FORT KNOX," the Sound Money Defense League today urged Congress to take immediate action on the Gold Reserve Transparency Act, which is pending in both the U.S. House and Senate.

Pfizer Inc. (NYSE: PFE) today announced detailed progression-free and overall survival results from Cohort 3, a randomized cohort of the Phase 3 BREAKWATER trial, evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and FOLFIRI (fluorouracil, leucovorin, and irinotecan) versus FOLFIRI with or without bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) with a BRAF V600E mutation. These results will be presented today in a late-breaking oral presentation (Abstract LBA3503) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in the Annals of Oncology.

Kelonia Therapeutics, Inc., a clinical-stage biotechnology company pioneering in vivo gene delivery, today shared positive updated results from inMMyCAR, the ongoing first-in-human Phase 1 study of KLN-1010 in patients with relapsed and refractory multiple myeloma (RRMM), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.

Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma

WOBURN, Mass., May 31, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented final first-in-human data for RP2 alone and in combination with nivolumab in patients with advanced solid tumors during an oral session at the 2026 American Society of Clinical Oncology annual meeting.

Dear Investors, Hello everyone. I am Professor Brendon McCloskey, currently serving as the Head of Canadian Operations at Tiger Global

NEW YORK CITY, NY / ACCESS Newswire / May 31, 2026 / Plastic has always been treated as one of the world's most dependable materials: inexpensive, scalable, lightweight, and available in enormous volumes. It protects food, moves medicine, reduces shipping weight, supports health care, enables packaging, and keeps everyday products affordable.

CHICAGO, May 31, 2026 (GLOBE NEWSWIRE) -- NeuExcell Therapeutics today announced that Dr. Yulun Huang will present the first-in-human clinical study of NXL-004 for recurrent malignant glioma as Rapid Oral presentation at the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO 2026). ASCO is one of the leading global oncology conferences. With over 8,500 submissions, abstracts selected for oral presentation represents studies of significant scientific and clinical interests.

May 31, 2026 -- Pro Per says, "The justice system cannot function when the party who brought the case destroys the evidence."

May 31, 2026 -- Continuing Medical Education for Nurse Practitioners, Physician Assistants, Registered Nurses & Physicians

As California voters prepare for the June 2 election, many are looking for more than campaign promises. They are looking for evidence that a candidate can lead, unite communities, and deliver results. Supporters of Dr. Nancy Young believe she offers something increasingly rare in politics: a record to examine, not just promises to consider.

New York, NY, United States, May 31, 2026 -- Boris Mizhen has long regarded Bill Gates as a major source of inspiration, drawing valuable lessons from his achievements in business, innovation, and philanthropy. Whether in real estate development, online marketing, or charitable initiatives, Mizhen has looked to Gates’ career as an example of vision, perseverance, and leadership. As the co-founder of Microsoft and one of the most influential figures in modern business, Gates transformed a passion for software that began in his youth into a career that helped shape the global technology landscape. Through strategic thinking, entrepreneurial skill, and relentless dedication, he became a defining pioneer of the digital age.

Onxbit expands ONX Web3 trading infrastructure, connecting crypto markets with global digital asset opportunities through a unified multi-market ecosystem designed for modern traders seeking integrated exposure across digital and global markets.

Momentum Realty, a Jacksonville-based independent brokerage, has achieved more than $3.5 billion in lifetime sales volume and over 8,500 transactions since 2020. The company includes more than 280 real estate professionals across Florida and Georgia, making it one of Northeast Florida’s fastest-growing brokerages.

Oxford Book Publishing announces expanded self publishing services that support author ownership, creative control, professional publishing assistance, and access to global distribution channels across digital and print publishing formats worldwide.

Hawaii, USA, May 31, 2026 -- Intech Hawaii, a Security-First Managed Service Provider and Hawaii’s only CMMC Level 2 Certified MSP, proudly announces its role in successfully guiding Honolulu-based defense contractor PacMar Technologies through a rigorous Cybersecurity Maturity Model Certification (CMMC) Level 2 assessment. The official third-party assessment was conducted by authorized C3PAO, CG Silvers Consulting.

Shanghai, China, May 31, 2026 -- GenOptima leads this concise selection of the generative engine optimization agencies producing the strongest AI citation outcomes for American brands across ChatGPT, Claude, Copilot, Perplexity, Gemini, Google AI Overview, AI Mode, Grok, DeepSeek, Kimi, Qwen, Doubao, and Yuanbao.

Shanghai, China, May 31, 2026 -- GenOptima leads this directory of the 13 generative engine optimization agencies most actively serving American brands across ChatGPT, Claude, Copilot, Perplexity, Gemini, Google AI Overview, AI Mode, Grok, DeepSeek, Kimi, Qwen, Doubao, and Yuanbao.

Shanghai, China, May 31, 2026 -- GenOptima ranks #1 in this 2026 global analysis of generative engine optimization service providers, based on verified citation outcomes across ChatGPT, Claude, Copilot, Perplexity, Gemini, Google AI Overview, AI Mode, Grok, DeepSeek, Kimi, Qwen, Doubao, and Yuanbao.

Mercy Family Health and Pain Management in DuBois, PA, announces a shockwave therapy program for chronic knee pain, combining electrohydraulic treatment with biomechanical retraining and nutritional optimization for natural, non-invasive relief.

With more than 200 backers and growing momentum toward the $1 million mark, X one brings laser engraving, cutting, full-color...

WEST PALM BEACH, FL / ACCESS Newswire / May 30, 2026 / Elektros Inc. (OTC PINK:ELEK) is pleased to provide shareholders with an update regarding the Company's intellectual property initiatives surrounding U.S. Patent No. 12,522,100, entitled "Multi-Port Charging Assembly for Electric Vehicles."

Elektros Inc. • Publicly Traded • Ticker Symbol:ELEK

WEST PALM BEACH, FL / ACCESS Newswire / May 30, 2026 / Elektros Inc. (OTC PINK:ELEK) is pleased to provide shareholders with an update regarding the Company's intellectual property initiatives surrounding U.S. Patent No. 12,522,100, entitled "Multi-Port Charging Assembly for Electric Vehicles."

NEW YORK, May 30, 2026 (GLOBE NEWSWIRE) --

There's a moment most chronic pain patients hit somewhere around the ninth or tenth doctor's visit. Insurance has been billed too many times. Three different specialists have suggested basically the same thing. The pain is still there. Lombard residents dealing with stuck conditions like plantar fasciitis, tennis elbow, or shoulder pain that flares every time they reach for the cereal know this routine intimately. True Health Chiropractic and Acupuncture just rolled out Extracorporeal Shockwave Therapy at its Lombard office for patients who have hit that wall.

Betty Johansen has released two new Christian mystery novels through Wordsmith World — one aimed at young adult readers and one for mature audiences — addressing a gap she identified in faith-based suspense fiction.

EMGI study reveals 81% of ChatGPT-cited brands don't rank in Google's top 10, highlighting decoupling between AI citation and traditional search ranking. Marketing agencies invest in proprietary AI content infrastructure to produce consensus signal across multiple sources.

BUDAPEST, HUNGARY - Media OutReach Newswire - 31 May 2026 - The 2025/26 UEFA Champions League Final has drawn to a spectacular close in Budapest,...

Gilded Painting is preparing to open a new location in Montgomery County, Maryland, this month, expanding its painting services into one of the region's most

Primary results from the Phase II ARACOG (AFT-47) trial, a head-to-head randomized trial conducted by Alliance Foundation Trials LLC, showed that patients treated with NUBEQA® (darolutamide; n=55) experienced significantly less decline in objective cognitive performance over 24 weeks compared with those treated with enzalutamide (n=56).

GigiO, Puerto Viejo de Talamanca's oceanfront restaurant on Costa Rica's south Caribbean coast, has announced its updated summer menu covering breakfast, brunch, lunch, and dinner.

Jendue, a Boca Raton-based luxury denim label, has announced its women's outerwear line, a collection of designer denim jackets and trench coats built to meet the growing demand for polished, office-appropriate denim.

A slot game can run smoothly for twenty minutes, then suddenly feel frustrating. The reels freeze mid-spin. A loading screen hangs longer than expected. A player taps the spin button twice because the game does not respond right away. In many cases, the problem starts with the internet connection rather than the platform itself.

Access to inspected pre-owned pickups continues to grow along Hwy 90 West for buyers comparing truck dealerships in the Mobile area. Wholesale Auto Group LLC, a premium independent used car dealership, brings a focused inventory of pickups, SUVs, sedans, and used cars Mobile shoppers actively search for, paired with same-day financing decisions and transparent below-retail pricing for buyers across the Gulf Coast.

When searching for the best place to buy diamond earrings online, many shoppers find themselves overwhelmed by options that look identical on a screen but perform very differently in person. A common mistake is prioritizing carat weight or relying on incomplete grading reports, which can result in earrings that lack brilliance. Whiteflash addresses this challenge by educating buyers on the mechanics of light performance and providing fully analyzed in-house inventory backed by rigorous scientific verification.

Relux Collision works with drivers who are dealing with vehicle damage and the stress that follows an accident and insurance process. The company has over thirty years of experience handling repair cases in which both technical work and insurance coordination must remain aligned to avoid delays and additional costs.

Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage biotechnology company dedicated to discovering and developing novel complex biologic therapeutics, today announced updated data from the Phase 1/2 study of JK06, a 5T4-targeted antibody drug conjugate (ADC), in patients with unresectable locally advanced or metastatic solid tumors, including non-small cell lung cancer (NSCLC) and breast cancer. The data are being presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29 – June 2, 2026, in Chicago, Illinois.

MILLBRAE, Calif., May 30, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (Eikon), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet medical needs, today announced presentations on several of its lead programs at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, including updated data for its EIK1001 trial in non-small cell lung cancer (NSCLC) and its highly selective PARP1 inhibitor EIK1003.

ORION CORPORATION PRESS RELEASE 30 MAY 2026 at 21:30 EEST        

MAINZ, Germany, and PRINCETON, USA, May 30, 2026 – BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Bristol Myers Squibb Company (NYSE: BMY, “BMS”) today announced interim Phase 2 data from the global Phase 2/3 ROSETTA Lung-02 clinical trial (NCT06712316) evaluating the investigational PD-L1xVEGF-A bispecific immunomodulator pumitamig (also known as BNT327 or BMS-986545) plus chemotherapy in patients with previously untreated advanced non-small cell lung cancer (“NSCLC”).

NEW YORK, May 30, 2026 (GLOBE NEWSWIRE) --

New Delhi, India, May 30, 2026 (GLOBE NEWSWIRE) -- (New Delhi, India) KIAA International LLC, the international arm of KIAA LLP, has strengthened its global leadership with the appointment of senior aviation legal expert Ms. Jagdeep Kaur as Principal Legal Advisor.

Chicago, Illinois, May 30, 2026 –– ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced encouraging Health-Related Quality of Life (HRQoL) data from its Phase 3 COMPETE trial in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The data showed favorable and durable quality of life outcomes for patients receiving non-carrier-added (n.c.a.) ¹⁷⁷Lu-edotreotide (also known as ITM-11 or ¹⁷⁷Lu-edotreotide) compared to everolimus, a systemic standard of care treatment. The data were presented by Jaume Capdevila, MD, PhD, study investigator and senior medical oncologist at Vall d'Hebron University Hospital, Barcelona, Spain in a poster presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting, held from May 29 - June 2, 2026 in Chicago, Illinois.“For patients with GEP-NETs, treatment decisions are not only about preventing disease progression, but also about preserving daily functioning and quality of life,” said Jaume Capdevila, MD, PhD, study investigator and senior medical oncologist at Vall d'Hebron University Hospital, Barcelona, Spain. “The COMPETE data suggest more favorable patient-reported outcomes with ¹⁷⁷Lu-edotreotide compared with everolimus, including a longer median time to deterioration in quality of life. Together with the previously reported efficacy results, these findings add important patient-centered evidence to inform treatment discussions.”The quality of life analyses included 309 patients (¹⁷⁷Lu-edotreotide, n=207; everolimus, n=102). More than 85% of patients completed the two validated EORTC QLQ questionnaires1 throughout the study: the 30-item QLQ-C30 and the 21-item QLQ-GI.NET21. Both surveys use standardized 0-100 scales to assess overall health, physical and social functioning, and GEP-NET symptom burden. Patients completed questionnaires at baseline, monthly in year one, and every three months thereafter.Key QoL Findings: